NEW WORLD DEV (00017): CHOW TAI FOOK company is in discussions with potential investors, but has not reached any agreement yet.
New World Development (00017) announced that, after further inquiries with Chow Tai Fook Enterprises, the company was informed that they have been in contact with some potential investors regarding possible investments in the company and have received suggestions from them. Chow Tai Fook Enterprises is currently in discussions with these potential investors, but no agreements have been reached with any of them, including on the amount, nature, or form of any potential investments. The company further learned from Chow Tai Fook Enterprises that, as of the date of this announcement, these suggestions do not appear to be intended to result in a full takeover offer for the company's shares, and there is no guarantee that these potential investments will take place.
NEW WORLD DEV(00017) announced that, following further inquiries with CHOW TAI FOOK Corporation, the company has been informed by CHOW TAI FOOK Corporation that they have been in contact with several potential investors regarding possible investments in the company and have received suggestions from them. CHOW TAI FOOK Corporation is currently in discussions with these potential investors, but have not reached any agreements with them, including regarding the amount, nature, or form of any potential investment. The company has further learned from CHOW TAI FOOK Corporation that, as of the date of this announcement, the suggestions made do not appear to intend to make a full tender offer for the company's shares, and there is no guarantee that such potential investments will take place.
Additionally, the company confirms that they are not aware of any other information that must be disclosed to avoid false market of the company's securities, and are not aware of any insider information that needs to be disclosed according to insider trading regulations.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


